DZ2751A1 - Composés calciolytiques nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant. - Google Patents

Composés calciolytiques nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.

Info

Publication number: DZ2751A1
Authority: DZ; Algeria
Prior art keywords: calciolytic; preparation; new; pharmaceutical compositions; compositions containing
Prior art date: 1998-04-08

Application number

DZ990052A

Other languages

English (en)

Inventor

Pradip Kumar Bhatnagar

Joelle Lorraine Burgess

James Francis Callahan

Raul Rollando Calvo

Del Eric G Mar

Maria Amparo Lago

Thomas The Nguyen

Original Assignee

Smithkline Beecham Corp

Nps Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-08

Filing date

1999-04-07

Publication date

2003-09-15

1999-04-07 Application filed by Smithkline Beecham Corp, Nps Pharma Inc filed Critical Smithkline Beecham Corp

2003-09-15 Application granted granted Critical

2003-09-15 Publication of DZ2751A1 publication Critical patent/DZ2751A1/fr

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/33—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring with cyano groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
- C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/22—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by carbon atoms having at least two bonds to oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/37—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by etherified hydroxy groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/06—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by carboxyl groups

DZ990052A 1998-04-08 1999-04-07 Composés calciolytiques nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant. DZ2751A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US8109398P	1998-04-08	1998-04-08

Publications (1)

Publication Number	Publication Date
DZ2751A1 true DZ2751A1 (fr)	2003-09-15

Family

ID=22162059

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ990052A DZ2751A1 (fr)	1998-04-08	1999-04-07	Composés calciolytiques nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.

Country Status (34)

Country	Link
US (1)	US6395919B1 (fr)
EP (1)	EP1070048B1 (fr)
JP (1)	JP2002510671A (fr)
KR (1)	KR20010042526A (fr)
CN (1)	CN1304401A (fr)
AP (1)	AP1271A (fr)
AR (1)	AR018177A1 (fr)
AT (1)	ATE303358T1 (fr)
AU (1)	AU752389B2 (fr)
BG (1)	BG104916A (fr)
BR (1)	BR9909486A (fr)
CA (1)	CA2327279A1 (fr)
CO (1)	CO5031246A1 (fr)
DE (1)	DE69927008T2 (fr)
DZ (1)	DZ2751A1 (fr)
EA (1)	EA200001039A1 (fr)
EG (1)	EG24178A (fr)
ES (1)	ES2247795T3 (fr)
HK (1)	HK1034243A1 (fr)
HU (1)	HUP0101346A3 (fr)
ID (1)	ID27004A (fr)
IL (1)	IL138918A0 (fr)
MX (1)	MXPA00009844A (fr)
MY (1)	MY121054A (fr)
NO (1)	NO20005006L (fr)
NZ (1)	NZ507288A (fr)
OA (1)	OA11499A (fr)
PE (1)	PE20000415A1 (fr)
PL (1)	PL343357A1 (fr)
SK (1)	SK14852000A3 (fr)
TR (1)	TR200002896T2 (fr)
UA (1)	UA58586C2 (fr)
WO (1)	WO1999051569A1 (fr)
ZA (1)	ZA200005369B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ECSP003590A (es) *	1999-07-31	2002-02-25	Smithkline Beecham Corp	Compuestos calcioliticos
AR030684A1 (es) *	2000-01-24	2003-09-03	Smithkline Beecham Corp	Compuestos calciliticos, uso de dichos compuestos en la manufactura de medicamentos, e intermediarios utiles en la preparacion de dichos compuestos
US20030018203A1 (en) *	2002-07-17	2003-01-23	Largo Maria Amparo	Calcilytic compounds
FR2812875B1 (fr)	2000-08-08	2003-12-12	Centre Nat Rech Scient	Nouvelles diamines possedant une activite modulatrice des casr et leur mode de preparation
EP1308436B1 (fr) *	2000-08-11	2008-10-15	Japan Tobacco Inc.	Antagonistes du recepteur de calcium
EP1383511B1 (fr) *	2000-10-25	2006-10-25	SmithKline Beecham Corporation	Composes calcilytiques
MY143244A (en)	2002-11-26	2011-04-15	Smithkline Beecham Corp	Calcilytic compounds
US7105537B2 (en)	2003-01-28	2006-09-12	Bristol-Myers Squibb Company	2-substituted cyclic amines as calcium sensing receptor modulators
US7205322B2 (en)	2003-02-12	2007-04-17	Bristol-Myers Squibb Company	Thiazolidine compounds as calcium sensing receptor modulators
PE20050460A1 (es)	2003-04-23	2005-07-08	Japan Tobacco Inc	COMPUESTOS HETEROCICLICOS COMO ANTAGONISTAS CaSR (RECEPTOR SENSIBLE AL CALCIO)
US7265145B2 (en)	2003-05-28	2007-09-04	Bristol-Myers Squibb Company	Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method
EP1630157A4 (fr)	2003-05-28	2007-05-23	Japan Tobacco Inc	Antagoniste de casr
WO2005077886A1 (fr) *	2004-02-06	2005-08-25	Smithkline Beecham Corporation	Composes calcilytiques
US7648965B2 (en)	2004-05-14	2010-01-19	Unigene Laboratories Inc.	Method for fostering bone formation and preservation
US7531518B2 (en) *	2004-05-14	2009-05-12	Unigene Laboratories Inc.	Method for fostering bone formation and preservation
US20060293667A1 (en) *	2005-05-19	2006-12-28	Agnes Vignery	Bone implant device and methods of using same
WO2007027548A2 (fr) *	2005-09-02	2007-03-08	Amgen Inc.	Methodes pour moduler l'equilibre du liquide intestinal
US8093299B2 (en) *	2007-03-30	2012-01-10	Amgen Inc.	Methods of treating bowel disorders
BRPI0922503A2 (pt)	2008-12-24	2018-11-06	Daiichi Sankyo Company, Limited	composto, composição farmacêutica, métodos para melhorar o metabolismo ósseo, e para previnir ou tratar osteoporose
WO2010103429A1 (fr)	2009-03-10	2010-09-16	Pfizer Inc.	Dérivés de l'acide 1,1-(diméthyl-éthylamino)-2-hydroxy-propoxy]-éthyl}-3-méthyl-biphényl-4-carboxylique utiles en tant qu'antagonistes des récepteurs du calcium
GB201217330D0 (en)	2012-09-28	2012-11-14	Univ Cardiff	Therapeutic for treating inflammatory lung disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2533210A1 (fr) *	1982-09-17	1984-03-23	Lyon I Universite Claude	Edulcorants de synthese
DE3301198A1 (de)	1983-01-15	1984-07-19	Hoechst Ag, 6230 Frankfurt	N-arylalkylamin-3-propoxypyridin-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische praeparate und deren verwendung
US5541204A (en)	1994-12-02	1996-07-30	Bristol-Myers Squibb Company	Aryloxypropanolamine β 3 adrenergic agonists
IL123677A0 (en)	1995-09-21	1998-10-30	Lilly Co Eli	Selective beta3 adrenergic agonists
DE69733649T2 (de) *	1996-04-09	2006-05-18	NPS Pharmaceuticals, Inc., Salt Lake City	Calcylitische verbindungen

1999
- 1999-04-06 MY MYPI99001327A patent/MY121054A/en unknown
- 1999-04-06 AR ARP990101554A patent/AR018177A1/es unknown
- 1999-04-06 PE PE1999000275A patent/PE20000415A1/es not_active Application Discontinuation
- 1999-04-07 DZ DZ990052A patent/DZ2751A1/fr active
- 1999-04-07 EG EG36999A patent/EG24178A/xx active
- 1999-04-08 EA EA200001039A patent/EA200001039A1/ru unknown
- 1999-04-08 MX MXPA00009844A patent/MXPA00009844A/es unknown
- 1999-04-08 ZA ZA200005369A patent/ZA200005369B/xx unknown
- 1999-04-08 JP JP2000542291A patent/JP2002510671A/ja not_active Withdrawn
- 1999-04-08 CN CN99807083A patent/CN1304401A/zh active Pending
- 1999-04-08 CA CA002327279A patent/CA2327279A1/fr not_active Abandoned
- 1999-04-08 TR TR2000/02896T patent/TR200002896T2/xx unknown
- 1999-04-08 AU AU34819/99A patent/AU752389B2/en not_active Ceased
- 1999-04-08 HU HU0101346A patent/HUP0101346A3/hu unknown
- 1999-04-08 EP EP99916516A patent/EP1070048B1/fr not_active Expired - Lifetime
- 1999-04-08 NZ NZ507288A patent/NZ507288A/en not_active IP Right Cessation
- 1999-04-08 BR BR9909486-0A patent/BR9909486A/pt not_active Application Discontinuation
- 1999-04-08 AP APAP/P/2000/001931A patent/AP1271A/en active
- 1999-04-08 SK SK1485-2000A patent/SK14852000A3/sk unknown
- 1999-04-08 IL IL13891899A patent/IL138918A0/xx unknown
- 1999-04-08 ES ES99916516T patent/ES2247795T3/es not_active Expired - Lifetime
- 1999-04-08 AT AT99916516T patent/ATE303358T1/de not_active IP Right Cessation
- 1999-04-08 US US09/647,793 patent/US6395919B1/en not_active Expired - Lifetime
- 1999-04-08 ID IDW20002001A patent/ID27004A/id unknown
- 1999-04-08 CO CO99020604A patent/CO5031246A1/es unknown
- 1999-04-08 PL PL99343357A patent/PL343357A1/xx not_active Application Discontinuation
- 1999-04-08 KR KR1020007011166A patent/KR20010042526A/ko not_active Application Discontinuation
- 1999-04-08 DE DE69927008T patent/DE69927008T2/de not_active Expired - Lifetime
- 1999-04-08 WO PCT/US1999/007722 patent/WO1999051569A1/fr not_active Application Discontinuation
- 1999-08-04 UA UA2000105670A patent/UA58586C2/uk unknown
2000
- 2000-10-04 NO NO20005006A patent/NO20005006L/no not_active Application Discontinuation
- 2000-10-06 OA OA1200000277A patent/OA11499A/en unknown
- 2000-11-07 BG BG104916A patent/BG104916A/xx unknown
2001
- 2001-07-09 HK HK01104722A patent/HK1034243A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
HUP0101346A2 (hu)	2001-08-28
WO1999051569A1 (fr)	1999-10-14
AP1271A (en)	2004-04-21
DE69927008D1 (de)	2005-10-06
PL343357A1 (en)	2001-08-13
NZ507288A (en)	2003-05-30
AP2000001931A0 (en)	2000-09-30
ZA200005369B (en)	2001-12-18
IL138918A0 (en)	2001-11-25
JP2002510671A (ja)	2002-04-09
UA58586C2 (uk)	2003-08-15
ES2247795T3 (es)	2006-03-01
SK14852000A3 (sk)	2001-05-10
EP1070048A4 (fr)	2001-11-07
CN1304401A (zh)	2001-07-18
BR9909486A (pt)	2001-11-06
ATE303358T1 (de)	2005-09-15
EA200001039A1 (ru)	2001-04-23
DE69927008T2 (de)	2006-03-16
ID27004A (id)	2001-02-22
AU3481999A (en)	1999-10-25
AR018177A1 (es)	2001-10-31
EP1070048A1 (fr)	2001-01-24
HK1034243A1 (en)	2001-10-19
PE20000415A1 (es)	2000-05-21
KR20010042526A (ko)	2001-05-25
US6395919B1 (en)	2002-05-28
CO5031246A1 (es)	2001-04-27
BG104916A (en)	2001-06-29
OA11499A (en)	2004-05-05
EG24178A (en)	2008-09-28
NO20005006D0 (no)	2000-10-04
EP1070048B1 (fr)	2005-08-31
AU752389B2 (en)	2002-09-19
CA2327279A1 (fr)	1999-10-14
MXPA00009844A (es)	2003-07-14
TR200002896T2 (tr)	2001-01-22
MY121054A (en)	2005-12-30
NO20005006L (no)	2000-10-04
HUP0101346A3 (en)	2003-03-28

Publication	Publication Date	Title
DZ2751A1 (fr)	2003-09-15	Composés calciolytiques nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
DZ2457A1 (fr)	2004-11-08	Derivés de nicotinamide nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
DZ2128A1 (fr)	2002-10-26	Composés nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2891A1 (fr)	2003-12-15	Dérivés de tétrahydroquinoléines substués nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
FR2718136B1 (fr)	1996-06-21	Composés aromatiques aminés, procédé pour leur obtention et compositions pharmaceutiques les contenant.
FR2780057B1 (fr)	2002-09-13	Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26687A1 (fr)	2004-12-20	4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
DZ2745A1 (fr)	2003-09-08	BicycloÄ2.2.1Üheptanes nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2890A1 (fr)	2003-12-15	4-Carboxamino-2-substitué-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositions pharmaceutiques les contenant.
CY2537B1 (fr)	2006-06-28	Composés hétérocycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant
MA26659A1 (fr)	2004-12-20	Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.
DZ1889A1 (fr)	2002-02-17	Dérivés de quinoléine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2300A1 (fr)	2002-12-25	Dérivés 6,5-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2299A1 (fr)	2002-12-25	Dérivés 6,6-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2773A1 (fr)	2003-12-01	Pyrazolopyrimidinones nouvelles procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2376A1 (fr)	2002-12-28	Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
DZ2962A1 (fr)	2004-03-15	Dérivés de 3-azabicycloÄ3,1,0Ühexane nouveaux, procédé pour leur préparation et compositions les contenant.
DZ2634A1 (fr)	2003-03-08	Dérivés de pleuromutiline nouveaux procédé pour leur préparation et compositions pharmaceutiques lescontenant.
MA26686A1 (fr)	2004-12-20	Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26630A1 (fr)	2004-12-20	4-phenylpyperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26638A1 (fr)	2004-12-20	Derives d'isothiazole nouveaux, procede pour leur preparation et compoositions pharmaceutiques les contenant
DZ1957A1 (fr)	2002-02-17	Dérivés de pipéridine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2395A1 (fr)	2003-06-04	Composés nouveaux a noyau dibenzocycloheptène procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2777A1 (fr)	2003-12-01	Dérivés de quinazolinamines nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2866A1 (fr)	2003-12-01	1-Aryl-3-arylméthyl-1,8-naphtyridine-4-(1H)-ones nouvelles, procédé pour leur préparation et compositions pharmaceutiques les contenant.